Welcome to the e-CCO Library!

P728: Effectiveness and quality of life (QoL) of Ustekinumab (UST) therapy in a Real-world Setting in Germany – First Results of the RUN-CD Study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Bokemeyer*1,2, S. Plachta-Danielzik3, N. Teich4, W. Mohl5, M. Hoffstadt6, A. Schweitzer7, M. von der Ohe8, T. Krause9, J. Höchstödter3, P. Hartmann1, B. Wiebe3, S. Schreiber2

Created: Friday, 22 February 2019, 9:41 AM
P728: Efficacy of anti-TNF treatment in patients with refractory ulcerative proctitis: Results from a French retrospective multi-centre national cohort
Year: 2018
Source: ECCO '18 Vienna
Authors:

G. Pineton de Chambrun1*, A. Amiot2, G. Bouguen3, S. Viennot4, R. Altwegg1, E. Louis5, M. Collins6, M. Fumery7, F. Poullenot8, L. Armengol9, A. Buisson10, V. Abitbol11, Y. Bouhnik12, D. Laharie8, P. Seksik13, S. Nancey14, P. Blanc1, M. Nachury15, L. Peyrin-Biroulet16

Created: Thursday, 21 February 2019, 9:14 AM
P728: Real world evidence for adalimumab biosimilar, MSB 11022, therapy in inflammatory bowel diseases: Adherence analysis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Cheung, S.(1)*;Truong, D.(1);
Created: Friday, 14 July 2023, 11:12 AM
P729 The SAPPHIRE registry: Safety of immunosuppression in a prospective cohort of inflammatory bowel disease patients with a HIstoRy of CancEr
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Axelrad1, J.F. Colombel2, E. Scherl3, D. Lukin3, S. Chang1, L. Chen1, J. Kwah4, A. Swaminath5, K. Sultan5, G. Lawlor6, C. Villagra2, J. Galanko7, V. Sharpless7, S. Itzkowitz2, New York Crohn’s and Colitis Organization (NYCCO)

Created: Thursday, 30 January 2020, 10:12 AM
P729: A ‘real-world’ retrospective multi-centre study comparing infliximab and adalimumab for the maintenance of remission in ulcerative colitis
Year: 2018
Source: ECCO '18 Vienna
Authors:

V. Kronsten1*, M. Colwill1, S. Nayeemuddin2, J. Limdi2,3, C. Selinger4, G. Scott5, L. Al-Hillawi6, S. Salehi6, P. Blaker6, G. Chung-Faye1, A. Kent1, P. Dubois1, B. Hayee1

Created: Thursday, 21 February 2019, 9:14 AM
P729: Evaluation of hepatobiliary pathologies using transient elastography in patients with inflammatory bowel disease: What about the effect of drugs?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ağargün, B.F.(1);Şenkal, İ.V.(2);Rustamzade, A.(2);Nuriyev, K.(2);İstemihan, Z.(2);İmanov, Z.(2);Genç, S.(2);Çelik, B.(3);Şahutoğulları, D.(3);Çavuş, B.(2);Çifcibaşı Örmeci, A.(2);Demir, K.(2);Beşışık, S.F.(2);Kaymakoğlu, S.(2);Akyüz, F.(2)*;
Created: Friday, 14 July 2023, 11:12 AM
P729: Faecal calprotectin and faecal immunochemical test have different values depending on mucosal status in patients with ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H. W. Kim*1, S. B. Park1, C. W. Choi1, D. H. Kang1, D. G. Ryu1

Created: Friday, 22 February 2019, 9:41 AM
P729: Increased requirement for steroids, thiopurines and intestinal surgery in Crohn's patients who are smokers at IBD diagnosis; a nationwide population based study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Alexakis C.*1, Saxena S.2, Chhaya V.1, Cecil E.2, Pollok R.1

Created: Wednesday, 20 February 2019, 10:36 AM
P730 Effectiveness and safety of endoscopic balloon dilation of colorectal strictures in Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. TILMANT1, M. serrero2, F. Poullenot3, G. Bouguen4, B. Pariente5, R. Altwegg6, P. Basile7, J. Filippi8, P. Vanelslander9, A. Buisson10, L. Vuitton11, A. Desjeux2, D. Laharie3, E. Le Balch4, M. Nachury5, L. Boivineau6, G. Savoye7, X. Hebuterne8, L. Poincloux10, A. Lamrani12, M. Fumery1

Created: Thursday, 30 January 2020, 10:12 AM
P730: Anti tumor necrosis factor treatment in Ulcerative Colitis: Real-world data and evaluation of current treatment targets (STRIDE II)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lundekvam, J.A.(1,2)*;Lie Høivik, M.(1,2);Anisdahl, K.(1,2);Cvancarova Småstuen, M.(3);Medhus, A.W.(1,2);
Created: Friday, 14 July 2023, 11:12 AM
P730: Disease phenotype of Korean paediatric Crohn's disease patients at diagnosis: a multicentre retrospective comparative study with EUROKIDS
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kang B.*1, Kim J.-E.2, Kim S.3, Kim M.J.4, Lee Y.M.5, Lee J.H.6, Lee J.-H.7, Lee H.J.8, Lee Y.9, Choe Y.H.1, Choe B.-H.2

Created: Wednesday, 20 February 2019, 10:36 AM
P730: High-dosed intravenous iron replacement therapy does not hinder drug-induced amelioration of disease activity in IBD patients with iron deficiency anaemia
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Stein1,2*, S. Vollmer3, W. Klemm4, K. Nip5, S. Weber-Mangal5, A. Dignass1,6

Created: Thursday, 21 February 2019, 9:14 AM
P730: Short and long-term outcome of acute severe colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Marwa*1, M. Ghanem1

Created: Friday, 22 February 2019, 9:41 AM
P731 Biologics use in elderly patients with IBD: Experience in a UK secondary care setting
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Alexakis, J. Robinson, R. Yeates, N. Ho-Yen, S. Mathew, M. Gallagher, C. Banks, K. Alexandropoulou

Created: Thursday, 30 January 2020, 10:12 AM
P731: Characteristics and follow-up on body composition, physical activity and quality of life in paediatric patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. K. Boros*1, O. Cseprekál2, K. E. Müller3, A. Dezsőfi1, G. Reusz1, G. Veres3

Created: Friday, 22 February 2019, 9:41 AM
P731: Effect on direct and indirect costs of switching Inflammatory Bowel Disease patients from intravenous to subcutaneous infliximab (CT-P13)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Carbery, I.(1)*;Broglio, G.(2);Clark, T.(1);Greer, D.(1);Alakkari, A.(1);Selinger, C.P.(1);
Created: Friday, 14 July 2023, 11:12 AM
P731: The impact of thiopurine drugs on the natural history and surgical outcome of ulcerative colitis: A cohort study
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Eriksson1, S. Rundquist1, Y. Cao2, S. Montgomery2, J. Halfvarson1*

Created: Thursday, 21 February 2019, 9:14 AM
P732 The clinical efficacy and safety of indigo naturalis in induction & maintenance therapy for moderate-to-severe ulcerative colitis: A single-centre prospective uncontrolled open-label study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. Matsuno1, A. Hirano1, T. Torisu1, Y. Fuyuno1, Y. Okamoto1, F. Shin1, M. Tomohiko1, J. Umeno1, Y. Hirakawa1,2, M. Esaki3, T. Kitazono1

Created: Thursday, 30 January 2020, 10:12 AM
P732: Clinical characteristics of inflammatory bowel disease in Belgian immigrants from Moroccan and Caucasian origin
Year: 2017
Source: ECCO '17 Barcelona
Authors:

de Ville de Goyet L., Moreels T., Denis M.A., De Vroey B., De Suray N., Mouradides C., Taha A., De Bouvere C., Piessevaux H., Dewit O.

Created: Wednesday, 20 February 2019, 10:36 AM
P732: Disability in older IBD patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

V. Asscher1*, L. Meijer1, S. Waars1, J. Slagboom1, A. Van der Meulen- de Jong1, S. Mooijaart2, J. Maljaars1

Created: Thursday, 21 February 2019, 9:14 AM